The current status of CLL treatment and how clinical practice will change
Daratumumab in the treatment of multiple myeloma
The use of CD20 antibodies in CLL patients with Notch1 mutations
Mantle cell lymphoma highlights from ASH 2016: Lysa, PHILEMON results and more
How can we assess quality of life in AML patients?